Scholar Rock Holding Corporation
SRRK
$41.08
-$0.91-2.17%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/12/2025
-
MarketBeat
12/3/2025
-
Simply Wall St
12/2/2025
-
Tickeron - Stocks
12/2/2025
-
TipRanks Financial Blog
12/1/2025
-
TipRanks Financial Blog
12/1/2025
-
MarketBeat
11/24/2025
-
Simply Wall St
11/24/2025
-
MarketBeat
11/24/2025
-
MarketBeat
11/23/2025
-
Simply Wall St
11/22/2025
-
Simply Wall St
11/22/2025
-
Tickeron - Stocks
11/21/2025
-
MarketBeat
11/21/2025
-
MarketBeat
11/21/2025
-
Tickeron - Stocks
11/19/2025
-
MarketBeat
11/19/2025
-
MarketBeat
11/19/2025
-
MarketBeat
11/18/2025
-
GuruFocus
11/18/2025
-
MarketBeat
11/18/2025
-
Business Wire
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Consensus Recommendation of "Buy" by Brokerages
11/18/2025
-
MarketBeat
11/17/2025
-
GuruFocus
11/16/2025
-
MarketBeat
11/16/2025
-
Insider Monkey
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 259 3860
Address
301 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein...
more